Clinical Trials Browser

OTHER × Recurrence × Thoracic × Clear all

NCT05669846 2026-03-09

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT05557474 2026-02-17

Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

Lung Neoplasms, Recurrence

NCT06007937 2026-02-05

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT04467723 2026-01-28

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03999710 2025-11-28

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Phase 1/2 Not yet recruiting

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT07097948 2025-08-01

Adjuvant

Phase 2 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT04358237 2025-06-04

LUPER

Phase 1/2 Completed

Recurrence, Small Cell Lung Carcinoma

NCT05701787 2025-05-22

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT05455424 2025-05-15

NERO

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Recurrence

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT03075072 2024-10-23

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Phase NA Active not recruiting

BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Recurrence

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT02889666 2024-04-17

CCODG-NSCLC

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03257722 2024-02-28

PIL

Phase 1/2 Terminated

4 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT06262386 2024-02-16

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

Phase NA Recruiting

Lung Neoplasms, Neoplastic Cells, Circulating, Recurrence

NCT05189054 2023-12-27

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Recurrence, Thoracic Neoplasms

NCT04636775 2023-12-11

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03215810 2023-07-24

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

20 enrolled 10 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Adenosquamous

NCT03758781 2023-04-14

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Phase 1 Completed

GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Neoplasm Metastasis, Recurrence

NCT03713944 2023-03-01

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

30 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04976296 2022-03-17

MRD Monitoring in Lung Cancer After Resection

Lung Neoplasms, Recurrence

NCT02963610 2021-12-30

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Phase 1/2 Terminated

3 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04634630 2021-06-01

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04813068 2021-05-28

Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy

Lung Neoplasms, Recurrence

NCT03791034 2021-05-11

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04797702 2021-03-15

CT32

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04292119 2021-03-10

Lorlatinib Combinations in Lung Cancer

Phase 1/2 Unknown

Lung Neoplasms, Recurrence

NCT04768491 2021-02-24

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01588821 2020-09-29

Cabozantinib in Advanced Solid Malignancies

Phase 2 Completed

37 enrolled 10 charts

GenitourinaryThoracic

Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT02492568 2020-08-17

PEMBRO-RT

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04492969 2020-07-31

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02713984 2020-03-19

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

Phase 1/2 Withdrawn

BreastCNSGastrointestinalGynecologicThoracic

Breast Neoplasms, Glioma, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT03613753 2020-02-05

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Phase 2 Unknown

Recurrence, Small Cell Lung Carcinoma

NCT01173523 2019-04-16

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

25 enrolled 8 charts

Recurrence, Small Cell Lung Carcinoma

NCT02623127 2019-01-23

KOSMIC

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Thymoma

NCT03029273 2019-01-17

NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC

Phase 1 Unknown

Lung Neoplasms, Recurrence

NCT02204761 2018-11-20

Proton Beam Re-Irradiation in Thoracic Cancers

Phase NA Completed

6 enrolled 10 charts

Recurrence, Thoracic Neoplasms

NCT02566421 2018-07-02

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Phase NA Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT02166658 2018-01-23

CaBaMet

Phase 2 Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT01511081 2017-12-07

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

Phase 2 Terminated

21 enrolled 5 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Large Cell

NCT01233687 2017-06-22

AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

49 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT00612677 2017-03-23

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Phase 2 Terminated

1 enrolled 3 charts

Lung Neoplasms, Recurrence

NCT01515969 2016-07-12

Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01189435 2015-11-18

Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib

Phase 2 Terminated

2 enrolled 3 charts

Lung Neoplasms, Recurrence

NCT00378404 2015-06-08

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT02281708 2014-11-03

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

Phase 3 Unknown

Lung Neoplasms, Recurrence

NCT01079481 2013-05-30

Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer

Phase 1 Completed

Recurrence, Small Cell Lung Carcinoma

NCT00284154 2013-03-13

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

Phase 2 Completed

51 enrolled 10 charts

Lung Neoplasms, Recurrence, Carcinoma, Small Cell

NCT00824746 2013-02-26

ReGaiN

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence